33 news items
Updated Linvoseltamab Data Showcase Continued Deepening of Responses in Patients with Heavily Pre-Treated Multiple Myeloma
REGN
16 Jun 24
) on Regeneron's business; and risks associated with intellectual property of other parties and pending or future litigation relating thereto (including
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN
REGN
15 Jun 24
of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN
REGN
13 Jun 24
, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered
Kevzara® (sarilumab) Approved by FDA for the Treatment of Active Polyarticular Juvenile Idiopathic Arthritis (pJIA)
REGN
11 Jun 24
litigation relating thereto (including without limitation the patent litigation and other related proceedings relating to EYLEA
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN
REGN
5 Jun 24
, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field
4da9wxtvoi4pawvfdi82 0kp0m24yh881ovnge37k9rhi3rb
REGN
3 Jun 24
firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class
kh4o 0nqdsjyq0cemu61s29yrgv9ml2mafm7tsts28dx3a
CRL
IQV
MAIA
31 May 24
informational and should not be taken as investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor
joxdfsx taj789kbusbjnrdfr38qjda
REGN
31 May 24
(such as the COVID-19 pandemic) on Regeneron's business; and risks associated with intellectual property of other parties and pending or future litigation
xc0eyou z31ar9czemvyy8i
REGN
31 May 24
StatementsThis press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended
giauef9bfw39q500ako29ygs2lo02zbc63fi705g6h vhy6ac4c8ui3u
REGN
31 May 24
pandemic) on Regeneron's business; and risks associated with intellectual property of other parties and pending or future litigation relating thereto
cyjexgbiql54ad8 w603m4xfzrwklp
REGN
31 May 24
release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking
d59yj
REGN
30 May 24
of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late
f4rfs
BHVN
REGN
29 May 24
This news release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995
pn4teaoyua4qtsvvkb
REGN
28 May 24
, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field
l4mfndu
REGN
23 May 24
pandemic) on Regeneron's business; and risks associated with intellectual property of other parties and pending or future litigation relating thereto
9z764sw kjepukbu37dyrl
REGN
22 May 24
in the areas of corporate, securities, and antitrust class litigation. Founded by the late
lixzx4d55v1emgu5o s78nvztedqmpax0g0vmu
REGN
20 May 24
, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field
8msg090qx9mysy9pw63xxj8lhiqlgfg82ftu7sd3w98kt32yc
REGN
20 May 24
StatementsThis press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act
t6koyz k72e0be2mf5ofn7ecl6dzsmn68a9jlrp1zv35k162r3002rdk1m0
REGN
20 May 24
with intellectual property of other parties and pending or future litigation relating thereto (including without limitation the patent litigation and other related
yt5fw2
DV
JBL
REGN
19 May 24
, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state